Apyx Medical Corp Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent
Apyx Medical Corp (APYX) reported Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-31.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity · last filed 2020-05-08
- Apyx Medical Corp income (loss) from discontinued operations, net of tax, attributable to parent for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Apyx Medical Corp income (loss) from discontinued operations, net of tax, attributable to parent for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Apyx Medical Corp income (loss) from discontinued operations, net of tax, attributable to parent for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- Apyx Medical Corp income (loss) from discontinued operations, net of tax, attributable to parent for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- Apyx Medical Corp income (loss) from discontinued operations, net of tax, attributable to parent for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Apyx Medical Corp income (loss) from discontinued operations, net of tax, attributable to parent for fiscal 2018 was $5.10M, a 40.85% decline from fiscal 2017.
- Apyx Medical Corp income (loss) from discontinued operations, net of tax, attributable to parent for fiscal 2017 was $8.62M, a 13.42% increase from fiscal 2016.
- Apyx Medical Corp income (loss) from discontinued operations, net of tax, attributable to parent for fiscal 2016 was $7.60M.
| Period end | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 6 month | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 9 month | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $0.00 derived: sum of 2 quarters · filed 2020-03-31 | $0.00 derived: sum of 3 quarters · filed 2020-03-31 | $0.00 10-K · filed 2020-03-31 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-15 | $0.00 derived: sum of 2 quarters · filed 2019-11-15 | $0.00 10-Q · filed 2019-11-15 | $37.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | $37.00K derived: sum of 3 quarters · filed 2020-05-08 | $577.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-03-31 | $0.00 10-Q/A · filed 2020-05-08 | $37.00K derived: sum of 2 quarters · filed 2020-05-08 | $577.00K derived: sum of 3 quarters · filed 2020-05-08 | $3.24M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $37.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $577.00K derived: sum of 2 quarters · filed 2020-05-08 | $3.24M derived: sum of 3 quarters · filed 2020-05-08 | $5.10M 10-K · filed 2020-03-31 |
| 2018-09-30 | $540.00K 10-Q/A · filed 2020-05-08 | $3.21M derived: sum of 2 quarters · filed 2020-05-08 | $5.06M 10-Q/A · filed 2020-05-08 | $7.21M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-06-30 | $2.67M 10-Q · filed 2019-08-07 | $4.52M 10-Q · filed 2019-08-07 | $6.67M derived: sum of 3 quarters · filed 2020-05-08 | $8.37M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-03-31 | $1.86M 10-Q/A · filed 2020-05-08 | $4.00M derived: sum of 2 quarters · filed 2020-05-08 | $5.70M derived: sum of 3 quarters · filed 2020-05-08 | |
| 2017-12-31 | $2.15M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $3.85M derived: sum of 2 quarters · filed 2020-05-08 | $8.62M 10-K · filed 2020-03-31 | |
| 2017-09-30 | $1.70M 10-Q/A · filed 2020-05-08 | $6.47M 10-Q/A · filed 2020-05-08 | ||
| 2016-12-31 | $7.60M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |